KYORIN Holdings, Inc. Reports Consolidated Financial Results for the Six Months Ended September 30, 2014; Provides Earnings and Dividend Guidance for the Full Year Ending March 31, 2015; Announces Dividend for the Second Quarter Ended September 30, 2014, Payable on December 5, 2014
November 06, 2014 at 05:09 pm IST
Share
KYORIN Holdings, Inc. reported consolidated earnings results for the six months ended September 30, 2014. For the six months, the company reported operating income of ¥4,587 million and net income of ¥3,495 million or ¥46.78 per basic share on net sales of ¥51,112 million against operating income of ¥6,213 million, and net income of ¥4,397 million or ¥58.85 per basic share on net sales of ¥50,851 million for the same period of last year. Ordinary income was ¥4,898 million against ¥6,531 million a year ago.
For the full year ending March 31, 2015, the company expects ordinary income of ¥13,800 million, operating income of ¥13,800 million, and net income of ¥11,600 million or ¥155.26 per share on net sales of ¥111,700 million.
The company announced a dividend of ¥20 per share for the second quarter ended September 30, 2014. Scheduled date for starting dividend payment is December 5, 2014.
The company expects to pay dividend of ¥32 per share for the year ending March 31, 2015.
Kyorin Pharmaceutical Co Ltd, formerly Kyorin Holdings Inc, is a Japan-based company mainly engaged in the pharmaceuticals business. The Pharmaceuticals segment is mainly engaged in the manufacture, purchase, sales and testing of pharmaceutical products, the purchase of raw materials for pharmaceuticals, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, the operations related to clinical trials and information gathering such as searching for drug discovery seeds, as well as the drug candidate compound discovery research and compound evaluation business. The Company also conducts the diagnostic businesses and verifies and creates research targets that are directly linked to drug discovery.
KYORIN Holdings, Inc. Reports Consolidated Financial Results for the Six Months Ended September 30, 2014; Provides Earnings and Dividend Guidance for the Full Year Ending March 31, 2015; Announces Dividend for the Second Quarter Ended September 30, 2014, Payable on December 5, 2014
KYORIN PHARMACEUTICAL CO., LTD. 
